Skip to content
Search

Latest Stories

Healthcare professionals in Scotland mull over ways to minimise environmental impact of prescribing

Healthcare professionals from across Scotland met to discuss how prescribers can support NHS Scotland's target to achieve net zero by 2040.

Royal Pharmaceutical Society (RPS) Scotland and the Academy of Medical Royal Colleges and Faculties in Scotland brought together healthcare leaders to discuss how everyone can work together to make prescribing more environmentally sustainable.


A representative of every healthcare profession that prescribes medicines was invited to the meeting, which included GPs, hospital doctors, pharmacists, nurses and other health professionals.

Medicines account for around a quarter of carbon emissions in the NHS.

At the meeting, key strategies to work in a more sustainable way were discussed, including:

  • How to prescribe more sustainably, by ensuring information about the environmental impact of medicines is available for prescribers and patients to encourage use of medicines which have a lower carbon footprint such as low carbon inhalers.
  • How to reduce medicines waste through regular medication reviews and improving repeat prescription ordering systems, as well as ensuring waste medicines are disposed of safely.
  • How patients, healthcare professionals and politicians can think more dynamically about healthcare and reducing reliance on prescribing by involving patients in decisions about whether to take a medicine or consider a clinically suitable alternative such as exercise or activity programmes.

Speaking at the round table discussion, Clare Morrison, RPS director for Scotland, said: “Climate change is everyone’s responsibility. As prescribing healthcare professionals, we are very aware of the significant responsibilities we have in achieving net zero, both within the NHS and across society.

“I’m proud of the leading role RPS is playing together with our colleagues from Scottish Academy of Medical Royal Colleges, to bring together healthcare professionals from across Scotland to discuss this very important issue.

“Clinicians being more mindful about the prescribing process will not only benefit the environment, but also patients, as a key part of this is ensuring that we’re always thinking about how we prescribe in a patient centred way that will enhance each patient’s outcomes.”

Dr David Shackles, joint chair of RCGP Scotland, added: “On behalf of the Academy of Medical Royal Colleges and Faculties in Scotland, I am delighted help bring together colleagues from across healthcare in Scotland to explore how we can help reduce the carbon footprint of our NHS.

“Reducing the environmental impact of prescribing is incredibly important if we are to reach Net Zero and as prescribers, we all have a role to play in helping to achieve this.

“Bringing together healthcare leaders to explore this issue is a landmark step. I very much look forward to the discussions and crucially, building on areas of progress to ensure we can work together and alongside policymakers to achieve the very best outcomes for the health of our patients and the planet.”

Dr Miles Mack, chair of the Academy of Medical Royal Colleges and Faculties in Scotland, said: “The Scottish Academy recognise climate change as a global public health issue. Mitigating its impact is vital to protect both the physical and mental health of patients and generations to come.

“As healthcare professionals who are responsible for prescribing to our patients, we each have a role to play in ensuring that our activities can, in so far as is possible and as is clinically appropriate, reduce harm caused to the environment.

“I am therefore very pleased to see healthcare professionals come together to discuss this important issue and strive for solutions to the environmental challenges posed by prescribing.”

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less